Skip to main content
. Author manuscript; available in PMC: 2014 Nov 10.
Published in final edited form as: J Urol. 2010 Jul;184(1):74–80. doi: 10.1016/j.juro.2010.03.032

Figure 3.

Figure 3

Cumulative incidence of progression to invasive disease (≥cT1) or early radical cystectomy (RC) in BCG responders (grey lines) or non-responder (black lines).